Not available
Quote | Solid Biosciences Inc. (NASDAQ:SLDB)
Last: | $5.96 |
---|---|
Change Percent: | 1.44% |
Open: | $6.18 |
Close: | $5.96 |
High: | $6.34 |
Low: | $5.735 |
Volume: | 661,821 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Solid Biosciences Inc. (NASDAQ:SLDB)
CHARLESTOWN, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced a grant of 11,847 restricted stock units (“...
CHARLESTOWN, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that the Company has been added to the broad-market Russell 3000 ® Index as ...
Message Board Posts | Solid Biosciences Inc. (NASDAQ:SLDB)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $SLDB News Article - Solid Biosciences to Present at Barclays Global Healthcare Confere | whytestocks | investorshangout | 03/07/2023 6:45:47 PM |
!5 = 1 RS. 42 = 6.30. | kzivann | investorshub | 10/31/2022 2:49:59 PM |
whytestocks: $SLDB News Article - SLDB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Me | whytestocks | investorshangout | 09/30/2022 2:10:47 PM |
whytestocks: $SLDB News Article - Solid Biosciences Announces Acquisition of AavantiBio and Concurre | whytestocks | investorshangout | 09/30/2022 1:55:48 PM |
SLDB looking for a run up tomorrow, should | Gizzer211 | investorshub | 03/14/2022 11:00:38 PM |
News, Short Squeeze, Breakout and More Instantly...
Solid Biosciences Inc. Company Name:
SLDB Stock Symbol:
NASDAQ Market:
Solid Biosciences Inc. Website:
CHARLESTOWN, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced a grant of 11,847 restricted stock units (“...
CHARLESTOWN, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that the Company has been added to the broad-market Russell 3000 ® Index as ...
2024-06-21 08:15:07 ET Piper Sandler analyst issues OVERWEIGHT recommendation for SLDB on June 21, 2024 06:49AM ET. The previous analyst recommendation was Overweight. SLDB was trading at $6.3 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...